The 12-gene colon cancer assay validation and utility: Summary of clinical evidence.

Authors

null

Emily Burke

Genomic Health, Inc., Redwood City, CA

Emily Burke , Haluk Tezcan , Margarita Lopatin , Kim Michelle Clark-Langone , Mark Lee , Steven Shak , Amy Pratt Sing

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2014 Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

General Poster Session C: Cancers of the Colon and Rectum

Track

Cancers of the Colon, Rectum, and Anus

Sub Track

Multidisciplinary Treatment

Citation

J Clin Oncol 32, 2014 (suppl 3; abstr 523)

DOI

10.1200/jco.2014.32.3_suppl.523

Abstract #

523

Poster Bd #

C28

Abstract Disclosures

Similar Posters

Poster

2014 ASCO Annual Meeting

The 12-gene colon cancer assay validation and utility: Summary of clinical evidence.

The 12-gene colon cancer assay validation and utility: Summary of clinical evidence.

First Author: Emily Burke

Poster

2019 Gastrointestinal Cancers Symposium

The effect of adjuvant chemotherapy for stage III colon cancer in elderly patients.

The effect of adjuvant chemotherapy for stage III colon cancer in elderly patients.

First Author: Naomi Hayashi

Poster

2014 ASCO Annual Meeting

Sustaining quality cancer care in the NCI Community Cancer Centers Program (NCCCP).

Sustaining quality cancer care in the NCI Community Cancer Centers Program (NCCCP).

First Author: Kathleen M. Castro

First Author: Soo Yeun Park